FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Delayed Deutsche Boerse AG 19:50:27 24/05/2024 BST | ||
| 9.74 EUR | +1.56% |
|
| Current month | +1.27% | ||
| 1 month | +6.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 9.74 | +1.56% |
| 23/05/24 | 9.59 | -2.64% |
| 22/05/24 | 9.85 | -5.29% |
| 21/05/24 | 10.4 | -2.26% |
| 20/05/24 | 10.64 | +1.14% |
Delayed Quote Deutsche Boerse AG
Last update May 24, 2024 at 07:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PG4QDG |
| ISIN | DE000PG4QDG3 |
| Date issued | 07/11/2023 |
| Strike | 141.9 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.75 € |
|---|---|
| Lowest since issue | 5.89 € |
| Spread | 0.22 € |
| Spread % | 2.21% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140
USD
Average target price
146.8
USD
Spread / Average Target
+4.83%
- Stock Market
- Certificates
- Certificat
